Global Intranasal Drug Delivery Market to Reach $59. 2 Billion by 2027. Amid the COVID-19 crisis, the global market for Intranasal Drug Delivery estimated at US$44. 7 Billion in the year 2020, is projected to reach a revised size of US$59.

New York, Sept. 07, 2020 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Global Intranasal Drug Delivery Industry” – https://www.reportlinker.com/p05436898/?utm_source=GNW
2 Billion by 2027, growing at a CAGR of 4.1% over the analysis period 2020-2027. Spray, one of the segments analyzed in the report, is projected to record a 4.5% CAGR and reach US$19.7 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Drop segment is readjusted to a revised 5% CAGR for the next 7-year period.

The U.S. Market is Estimated at $12.1 Billion, While China is Forecast to Grow at 6.3% CAGR

The Intranasal Drug Delivery market in the U.S. is estimated at US$12.1 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$11.8 Billion by the year 2027 trailing a CAGR of 6.4% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.3% and 3.7% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 2.5% CAGR.

Gel Segment to Record 3.6% CAGR

In the global Gel segment, USA, Canada, Japan, China and Europe will drive the 3.2% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$8 Billion in the year 2020 will reach a projected size of US$10 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$7.8 Billion by the year 2027, while Latin America will expand at a 4.5% CAGR through the analysis period. We bring years of research experience to this 15th edition of our report. The 307-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

  • Aegis Therapeutics LLC

  • AptarGroup, Inc.

  • AstraZeneca Plc

  • Becton Dickinson and Company

  • GlaxoSmithKline Plc

  • Johnson & Johnson

  • Marina Biotech, Inc.

  • MedImmune, Inc.

  • Merck & Co., Inc.

  • Nemera

  • Novartis AG

  • OptiNose US Inc.

  • Pfizer Inc.

  • Valeant Pharmaceuticals International, Inc.

Read the full report: https://www.reportlinker.com/p05436898/?utm_source=GNW

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Impact of Covid-19 and a Looming Global Recession
A Prelude
Intranasal Cavity: An Attractive Drug Delivery Route to Cross
the Blood Brain Barrier
Recent Market Activity
Factors Inhibiting Nose-to-Brain Transportation of Drugs
Bioavailability: An Important Facet of Intranasal Drug Delivery
Outlook
Nasal Drug Delivery Devices & Equipment
Traditional Vs. Advanced Intranasal Drug Formulation Types
Global Competitor Market Shares
Intranasal Drug Delivery Competitor Market Share Scenario
Worldwide (in %): 2018 & 2029

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS
Burgeoning Geriatric Populace Spurs Growing Demand for
Intranasal Drug Therapies
Nasal Drug Delivery Offers New Opportunities for Drug
Developers as Patent Cliffs Usher in Dusk of Blockbuster Era
Pharmaceutical and Medical Device Companies Vying to Develop
New Intranasal Therapeutics for Allergic Rhinitis Patients
The US – FDA Approved Intranasal Corticosteroids (INAC) and
Intranasal Antihistamines (INAH) for Treating Allergic
Rhinitis
The US – FDA Approved Nasal Spray Medication Types (excluding
INAC & INAH) for Allergic Rhinitis Treatment
The US – FDA Approved Intranasal Corticosteroids (INAC) and
Intranasal Antihistamines (INAH) for Treating Allergic
Rhinitis
The US – FDA Approved Nasal Spray Medication Types (excluding
INAC & INAH) for Allergic Rhinitis Treatment
Intranasal Corticosteroids – A Potential Treatment for
Debilitating Chronic Rhinosinusitis Disease
Self-Administration of Drugs Brings Intranasal Drug Delivery
into the Spotlight
Innovation in Drug Delivery: A Talisman for Success
Active Pharmaceutical Ingredients Used in Formulations for
Nasal Drug Delivery with Related Indications
Controlled Release Technology Is the Buzz Word
Increasing R&D Unlocks New Therapeutic Areas for Nasal Drug
Delivery
Tight Junction Biology: A Key Speed Breaker in Commercialization
RNA Interference (RNAi): A Tool to Manipulate Tight Junctions
Research Studies Authenticate Benefits of Bi-Directional Nasal
Drug Delivery
Growing Interest for Preservative-free Nasal Spray Formulations
Multi-Dose Containers Developed to Offer Resistance against
Microbial Contamination

4. GLOBAL MARKET PERSPECTIVE
Table 1: Intranasal Drug Delivery Global Market Estimates and
Forecasts in US$ Million by Region/Country: 2020-2027

Table 2: Intranasal Drug Delivery Global Retrospective Market
Scenario in US$ Million by Region/Country: 2012-2019

Table 3: Intranasal Drug Delivery Market Share Shift across Key
Geographies Worldwide: 2012 VS 2020 VS 2027

Table 4: Spray (Dosage Form) World Market by Region/Country in
US$ Million: 2020 to 2027

Table 5: Spray (Dosage Form) Historic Market Analysis by
Region/Country in US$ Million: 2012 to 2019

Table 6: Spray (Dosage Form) Market Share Breakdown of
Worldwide Sales by Region/Country: 2012 VS 2020 VS 2027

Table 7: Drop (Dosage Form) Potential Growth Markets Worldwide
in US$ Million: 2020 to 2027

Table 8: Drop (Dosage Form) Historic Market Perspective by
Region/Country in US$ Million: 2012 to 2019

Table 9: Drop (Dosage Form) Market Sales Breakdown by
Region/Country in Percentage: 2012 VS 2020 VS 2027

Table 10: Gel (Dosage Form) Geographic Market Spread Worldwide
in US$ Million: 2020 to 2027

Table 11: Gel (Dosage Form) Region Wise Breakdown of Global
Historic Demand in US$ Million: 2012 to 2019

Table 12: Gel (Dosage Form) Market Share Distribution in
Percentage by Region/Country: 2012 VS 2020 VS 2027

Table 13: Powder (Dosage Form) World Market Estimates and
Forecasts by Region/Country in US$ Million: 2020 to 2027

Table 14: Powder (Dosage Form) Market Historic Review by
Region/Country in US$ Million: 2012 to 2019

Table 15: Powder (Dosage Form) Market Share Breakdown by
Region/Country: 2012 VS 2020 VS 2027

Table 16: Nasal Congestion (Application) Worldwide Latent
Demand Forecasts in US$ Million by Region/Country: 2020-2027

Table 17: Nasal Congestion (Application) Global Historic
Analysis in US$ Million by Region/Country: 2012-2019

Table 18: Nasal Congestion (Application) Distribution of Global
Sales by Region/Country: 2012 VS 2020 VS 2027

Table 19: Rhinitis (Application) Sales Estimates and Forecasts
in US$ Million by Region/Country for the Years 2020 through
2027

Table 20: Rhinitis (Application) Analysis of Historic Sales in
US$ Million by Region/Country for the Years 2012 to 2019

Table 21: Rhinitis (Application) Global Market Share
Distribution by Region/Country for 2012, 2020, and 2027

Table 22: Asthma (Application) Global Opportunity Assessment in
US$ Million by Region/Country: 2020-2027

Table 23: Asthma (Application) Historic Sales Analysis in US$
Million by Region/Country: 2012-2019

Table 24: Asthma (Application) Percentage Share Breakdown of
Global Sales by Region/Country: 2012 VS 2020 VS 2027

Table 25: Other Applications (Application) Worldwide Sales in
US$ Million by Region/Country: 2020-2027

Table 26: Other Applications (Application) Historic Demand
Patterns in US$ Million by Region/Country: 2012-2019

Table 27: Other Applications (Application) Market Share Shift
across Key Geographies: 2012 VS 2020 VS 2027

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES
Market Facts & Figures
US Intranasal Drug Delivery Market Share (in %) by Company:
2018 & 2025
Market Analytics
Table 28: United States Intranasal Drug Delivery Market
Estimates and Projections in US$ Million by Dosage Form: 2020
to 2027

Table 29: Intranasal Drug Delivery Market in the United States
by Dosage Form: A Historic Review in US$ Million for 2012-2019

Table 30: United States Intranasal Drug Delivery Market Share
Breakdown by Dosage Form: 2012 VS 2020 VS 2027

Table 31: United States Intranasal Drug Delivery Latent Demand
Forecasts in US$ Million by Application: 2020 to 2027

Table 32: Intranasal Drug Delivery Historic Demand Patterns in
the United States by Application in US$ Million for 2012-2019

Table 33: Intranasal Drug Delivery Market Share Breakdown in
the United States by Application: 2012 VS 2020 VS 2027

CANADA
Table 34: Canadian Intranasal Drug Delivery Market Estimates
and Forecasts in US$ Million by Dosage Form: 2020 to 2027

Table 35: Canadian Intranasal Drug Delivery Historic Market
Review by Dosage Form in US$ Million: 2012-2019

Table 36: Intranasal Drug Delivery Market in Canada: Percentage
Share Breakdown of Sales by Dosage Form for 2012, 2020, and
2027

Table 37: Canadian Intranasal Drug Delivery Market Quantitative
Demand Analysis in US$ Million by Application: 2020 to 2027

Table 38: Intranasal Drug Delivery Market in Canada:
Summarization of Historic Demand Patterns in US$ Million by
Application for 2012-2019

Table 39: Canadian Intranasal Drug Delivery Market Share
Analysis by Application: 2012 VS 2020 VS 2027

JAPAN
Table 40: Japanese Market for Intranasal Drug Delivery: Annual
Sales Estimates and Projections in US$ Million by Dosage Form
for the Period 2020-2027

Table 41: Intranasal Drug Delivery Market in Japan: Historic
Sales Analysis in US$ Million by Dosage Form for the Period
2012-2019

Table 42: Japanese Intranasal Drug Delivery Market Share
Analysis by Dosage Form: 2012 VS 2020 VS 2027

Table 43: Japanese Demand Estimates and Forecasts for
Intranasal Drug Delivery in US$ Million by Application: 2020 to
2027

Table 44: Japanese Intranasal Drug Delivery Market in US$
Million by Application: 2012-2019

Table 45: Intranasal Drug Delivery Market Share Shift in Japan
by Application: 2012 VS 2020 VS 2027

CHINA
Table 46: Chinese Intranasal Drug Delivery Market Growth
Prospects in US$ Million by Dosage Form for the Period
2020-2027

Table 47: Intranasal Drug Delivery Historic Market Analysis in
China in US$ Million by Dosage Form: 2012-2019

Table 48: Chinese Intranasal Drug Delivery Market by Dosage
Form: Percentage Breakdown of Sales for 2012, 2020, and 2027

Table 49: Chinese Demand for Intranasal Drug Delivery in US$
Million by Application: 2020 to 2027

Table 50: Intranasal Drug Delivery Market Review in China in
US$ Million by Application: 2012-2019

Table 51: Chinese Intranasal Drug Delivery Market Share
Breakdown by Application: 2012 VS 2020 VS 2027

EUROPE
Market Facts & Figures
European Intranasal Drug Delivery Market: Competitor Market
Share Scenario (in %) for 2018 & 2025
Market Analytics
Table 52: European Intranasal Drug Delivery Market Demand
Scenario in US$ Million by Region/Country: 2020-2027

Table 53: Intranasal Drug Delivery Market in Europe: A Historic
Market Perspective in US$ Million by Region/Country for the
Period 2012-2019

Table 54: European Intranasal Drug Delivery Market Share Shift
by Region/Country: 2012 VS 2020 VS 2027

Table 55: European Intranasal Drug Delivery Market Estimates
and Forecasts in US$ Million by Dosage Form: 2020-2027

Table 56: Intranasal Drug Delivery Market in Europe in US$
Million by Dosage Form: A Historic Review for the Period
2012-2019

Table 57: European Intranasal Drug Delivery Market Share
Breakdown by Dosage Form: 2012 VS 2020 VS 2027

Table 58: European Intranasal Drug Delivery Addressable Market
Opportunity in US$ Million by Application: 2020-2027

Table 59: Intranasal Drug Delivery Market in Europe:
Summarization of Historic Demand in US$ Million by Application
for the Period 2012-2019

Table 60: European Intranasal Drug Delivery Market Share
Analysis by Application: 2012 VS 2020 VS 2027

FRANCE
Table 61: Intranasal Drug Delivery Market in France by Dosage
Form: Estimates and Projections in US$ Million for the Period
2020-2027

Table 62: French Intranasal Drug Delivery Historic Market
Scenario in US$ Million by Dosage Form: 2012-2019

Table 63: French Intranasal Drug Delivery Market Share Analysis
by Dosage Form: 2012 VS 2020 VS 2027

Table 64: Intranasal Drug Delivery Quantitative Demand Analysis
in France in US$ Million by Application: 2020-2027

Table 65: French Intranasal Drug Delivery Historic Market
Review in US$ Million by Application: 2012-2019

Table 66: French Intranasal Drug Delivery Market Share
Analysis: A 17-Year Perspective by Application for 2012, 2020,
and 2027

GERMANY
Table 67: Intranasal Drug Delivery Market in Germany: Recent
Past, Current and Future Analysis in US$ Million by Dosage Form
for the Period 2020-2027

Table 68: German Intranasal Drug Delivery Historic Market
Analysis in US$ Million by Dosage Form: 2012-2019

Table 69: German Intranasal Drug Delivery Market Share
Breakdown by Dosage Form: 2012 VS 2020 VS 2027

Table 70: Intranasal Drug Delivery Market in Germany: Annual
Sales Estimates and Forecasts in US$ Million by Application for
the Period 2020-2027

Table 71: German Intranasal Drug Delivery Market in Retrospect
in US$ Million by Application: 2012-2019

Table 72: Intranasal Drug Delivery Market Share Distribution in
Germany by Application: 2012 VS 2020 VS 2027

ITALY
Table 73: Italian Intranasal Drug Delivery Market Growth
Prospects in US$ Million by Dosage Form for the Period
2020-2027

Table 74: Intranasal Drug Delivery Historic Market Analysis in
Italy in US$ Million by Dosage Form: 2012-2019

Table 75: Italian Intranasal Drug Delivery Market by Dosage
Form: Percentage Breakdown of Sales for 2012, 2020, and 2027

Table 76: Italian Demand for Intranasal Drug Delivery in US$
Million by Application: 2020 to 2027

Table 77: Intranasal Drug Delivery Market Review in Italy in
US$ Million by Application: 2012-2019

Table 78: Italian Intranasal Drug Delivery Market Share
Breakdown by Application: 2012 VS 2020 VS 2027

UNITED KINGDOM
Table 79: United Kingdom Market for Intranasal Drug Delivery:
Annual Sales Estimates and Projections in US$ Million by Dosage
Form for the Period 2020-2027

Table 80: Intranasal Drug Delivery Market in the United
Kingdom: Historic Sales Analysis in US$ Million by Dosage Form
for the Period 2012-2019

Table 81: United Kingdom Intranasal Drug Delivery Market Share
Analysis by Dosage Form: 2012 VS 2020 VS 2027

Table 82: United Kingdom Demand Estimates and Forecasts for
Intranasal Drug Delivery in US$ Million by Application: 2020 to
2027

Table 83: United Kingdom Intranasal Drug Delivery Market in US$
Million by Application: 2012-2019

Table 84: Intranasal Drug Delivery Market Share Shift in the
United Kingdom by Application: 2012 VS 2020 VS 2027

SPAIN
Table 85: Spanish Intranasal Drug Delivery Market Estimates and
Forecasts in US$ Million by Dosage Form: 2020 to 2027

Table 86: Spanish Intranasal Drug Delivery Historic Market
Review by Dosage Form in US$ Million: 2012-2019

Table 87: Intranasal Drug Delivery Market in Spain: Percentage
Share Breakdown of Sales by Dosage Form for 2012, 2020, and
2027

Table 88: Spanish Intranasal Drug Delivery Market Quantitative
Demand Analysis in US$ Million by Application: 2020 to 2027

Table 89: Intranasal Drug Delivery Market in Spain:
Summarization of Historic Demand Patterns in US$ Million by
Application for 2012-2019

Table 90: Spanish Intranasal Drug Delivery Market Share
Analysis by Application: 2012 VS 2020 VS 2027

RUSSIA
Table 91: Russian Intranasal Drug Delivery Market Estimates and
Projections in US$ Million by Dosage Form: 2020 to 2027

Table 92: Intranasal Drug Delivery Market in Russia by Dosage
Form: A Historic Review in US$ Million for 2012-2019

Table 93: Russian Intranasal Drug Delivery Market Share
Breakdown by Dosage Form: 2012 VS 2020 VS 2027

Table 94: Russian Intranasal Drug Delivery Latent Demand
Forecasts in US$ Million by Application: 2020 to 2027

Table 95: Intranasal Drug Delivery Historic Demand Patterns in
Russia by Application in US$ Million for 2012-2019

Table 96: Intranasal Drug Delivery Market Share Breakdown in
Russia by Application: 2012 VS 2020 VS 2027

REST OF EUROPE
Table 97: Rest of Europe Intranasal Drug Delivery Market
Estimates and Forecasts in US$ Million by Dosage Form:
2020-2027

Table 98: Intranasal Drug Delivery Market in Rest of Europe in
US$ Million by Dosage Form: A Historic Review for the Period
2012-2019

Table 99: Rest of Europe Intranasal Drug Delivery Market Share
Breakdown by Dosage Form: 2012 VS 2020 VS 2027

Table 100: Rest of Europe Intranasal Drug Delivery Addressable
Market Opportunity in US$ Million by Application: 2020-2027

Table 101: Intranasal Drug Delivery Market in Rest of Europe:
Summarization of Historic Demand in US$ Million by Application
for the Period 2012-2019

Table 102: Rest of Europe Intranasal Drug Delivery Market Share
Analysis by Application: 2012 VS 2020 VS 2027

ASIA-PACIFIC
Table 103: Asia-Pacific Intranasal Drug Delivery Market
Estimates and Forecasts in US$ Million by Region/Country:
2020-2027

Table 104: Intranasal Drug Delivery Market in Asia-Pacific:
Historic Market Analysis in US$ Million by Region/Country for
the Period 2012-2019

Table 105: Asia-Pacific Intranasal Drug Delivery Market Share
Analysis by Region/Country: 2012 VS 2020 VS 2027

Table 106: Intranasal Drug Delivery Market in Asia-Pacific by
Dosage Form: Estimates and Projections in US$ Million for the
Period 2020-2027

Table 107: Asia-Pacific Intranasal Drug Delivery Historic
Market Scenario in US$ Million by Dosage Form: 2012-2019

Table 108: Asia-Pacific Intranasal Drug Delivery Market Share
Analysis by Dosage Form: 2012 VS 2020 VS 2027

Table 109: Intranasal Drug Delivery Quantitative Demand
Analysis in Asia-Pacific in US$ Million by Application:
2020-2027

Table 110: Asia-Pacific Intranasal Drug Delivery Historic
Market Review in US$ Million by Application: 2012-2019

Table 111: Asia-Pacific Intranasal Drug Delivery Market Share
Analysis: A 17-Year Perspective by Application for 2012, 2020,
and 2027

AUSTRALIA
Table 112: Intranasal Drug Delivery Market in Australia: Recent
Past, Current and Future Analysis in US$ Million by Dosage Form
for the Period 2020-2027

Table 113: Australian Intranasal Drug Delivery Historic Market
Analysis in US$ Million by Dosage Form: 2012-2019

Table 114: Australian Intranasal Drug Delivery Market Share
Breakdown by Dosage Form: 2012 VS 2020 VS 2027

Table 115: Intranasal Drug Delivery Market in Australia: Annual
Sales Estimates and Forecasts in US$ Million by Application for
the Period 2020-2027

Table 116: Australian Intranasal Drug Delivery Market in
Retrospect in US$ Million by Application: 2012-2019

Table 117: Intranasal Drug Delivery Market Share Distribution
in Australia by Application: 2012 VS 2020 VS 2027

INDIA
Table 118: Indian Intranasal Drug Delivery Market Estimates and
Forecasts in US$ Million by Dosage Form: 2020 to 2027

Table 119: Indian Intranasal Drug Delivery Historic Market
Review by Dosage Form in US$ Million: 2012-2019

Table 120: Intranasal Drug Delivery Market in India: Percentage
Share Breakdown of Sales by Dosage Form for 2012, 2020, and
2027

Table 121: Indian Intranasal Drug Delivery Market Quantitative
Demand Analysis in US$ Million by Application: 2020 to 2027

Table 122: Intranasal Drug Delivery Market in India:
Summarization of Historic Demand Patterns in US$ Million by
Application for 2012-2019

Table 123: Indian Intranasal Drug Delivery Market Share
Analysis by Application: 2012 VS 2020 VS 2027

SOUTH KOREA
Table 124: Intranasal Drug Delivery Market in South Korea:
Recent Past, Current and Future Analysis in US$ Million by
Dosage Form for the Period 2020-2027

Table 125: South Korean Intranasal Drug Delivery Historic
Market Analysis in US$ Million by Dosage Form: 2012-2019

Table 126: Intranasal Drug Delivery Market Share Distribution
in South Korea by Dosage Form: 2012 VS 2020 VS 2027

Table 127: Intranasal Drug Delivery Market in South Korea:
Recent Past, Current and Future Analysis in US$ Million by
Application for the Period 2020-2027

Table 128: South Korean Intranasal Drug Delivery Historic
Market Analysis in US$ Million by Application: 2012-2019

Table 129: Intranasal Drug Delivery Market Share Distribution
in South Korea by Application: 2012 VS 2020 VS 2027

REST OF ASIA-PACIFIC
Table 130: Rest of Asia-Pacific Market for Intranasal Drug
Delivery: Annual Sales Estimates and Projections in US$ Million
by Dosage Form for the Period 2020-2027

Table 131: Intranasal Drug Delivery Market in Rest of
Asia-Pacific: Historic Sales Analysis in US$ Million by Dosage
Form for the Period 2012-2019

Table 132: Rest of Asia-Pacific Intranasal Drug Delivery Market
Share Analysis by Dosage Form: 2012 VS 2020 VS 2027

Table 133: Rest of Asia-Pacific Demand Estimates and Forecasts
for Intranasal Drug Delivery in US$ Million by Application:
2020 to 2027

Table 134: Rest of Asia-Pacific Intranasal Drug Delivery Market
in US$ Million by Application: 2012-2019

Table 135: Intranasal Drug Delivery Market Share Shift in Rest
of Asia-Pacific by Application: 2012 VS 2020 VS 2027

LATIN AMERICA
Table 136: Latin American Intranasal Drug Delivery Market
Trends by Region/Country in US$ Million: 2020-2027

Table 137: Intranasal Drug Delivery Market in Latin America in
US$ Million by Region/Country: A Historic Perspective for the
Period 2012-2019

Table 138: Latin American Intranasal Drug Delivery Market
Percentage Breakdown of Sales by Region/Country: 2012, 2020,
and 2027

Table 139: Latin American Intranasal Drug Delivery Market
Growth Prospects in US$ Million by Dosage Form for the Period
2020-2027

Table 140: Intranasal Drug Delivery Historic Market Analysis in
Latin America in US$ Million by Dosage Form: 2012-2019

Table 141: Latin American Intranasal Drug Delivery Market by
Dosage Form: Percentage Breakdown of Sales for 2012, 2020, and
2027

Table 142: Latin American Demand for Intranasal Drug Delivery
in US$ Million by Application: 2020 to 2027

Table 143: Intranasal Drug Delivery Market Review in Latin
America in US$ Million by Application: 2012-2019

Table 144: Latin American Intranasal Drug Delivery Market Share
Breakdown by Application: 2012 VS 2020 VS 2027

ARGENTINA
Table 145: Argentinean Intranasal Drug Delivery Market
Estimates and Forecasts in US$ Million by Dosage Form:
2020-2027

Table 146: Intranasal Drug Delivery Market in Argentina in US$
Million by Dosage Form: A Historic Review for the Period
2012-2019

Table 147: Argentinean Intranasal Drug Delivery Market Share
Breakdown by Dosage Form: 2012 VS 2020 VS 2027

Table 148: Argentinean Intranasal Drug Delivery Addressable
Market Opportunity in US$ Million by Application: 2020-2027

Table 149: Intranasal Drug Delivery Market in Argentina:
Summarization of Historic Demand in US$ Million by Application
for the Period 2012-2019

Table 150: Argentinean Intranasal Drug Delivery Market Share
Analysis by Application: 2012 VS 2020 VS 2027

BRAZIL
Table 151: Intranasal Drug Delivery Market in Brazil by Dosage
Form: Estimates and Projections in US$ Million for the Period
2020-2027

Table 152: Brazilian Intranasal Drug Delivery Historic Market
Scenario in US$ Million by Dosage Form: 2012-2019

Table 153: Brazilian Intranasal Drug Delivery Market Share
Analysis by Dosage Form: 2012 VS 2020 VS 2027

Table 154: Intranasal Drug Delivery Quantitative Demand
Analysis in Brazil in US$ Million by Application: 2020-2027

Table 155: Brazilian Intranasal Drug Delivery Historic Market
Review in US$ Million by Application: 2012-2019

Table 156: Brazilian Intranasal Drug Delivery Market Share
Analysis: A 17-Year Perspective by Application for 2012, 2020,
and 2027

MEXICO
Table 157: Intranasal Drug Delivery Market in Mexico: Recent
Past, Current and Future Analysis in US$ Million by Dosage Form
for the Period 2020-2027

Table 158: Mexican Intranasal Drug Delivery Historic Market
Analysis in US$ Million by Dosage Form: 2012-2019

Table 159: Mexican Intranasal Drug Delivery Market Share
Breakdown by Dosage Form: 2012 VS 2020 VS 2027

Table 160: Intranasal Drug Delivery Market in Mexico: Annual
Sales Estimates and Forecasts in US$ Million by Application for
the Period 2020-2027

Table 161: Mexican Intranasal Drug Delivery Market in
Retrospect in US$ Million by Application: 2012-2019

Table 162: Intranasal Drug Delivery Market Share Distribution
in Mexico by Application: 2012 VS 2020 VS 2027

REST OF LATIN AMERICA
Table 163: Rest of Latin America Intranasal Drug Delivery
Market Estimates and Projections in US$ Million by Dosage Form:
2020 to 2027

Table 164: Intranasal Drug Delivery Market in Rest of Latin
America by Dosage Form: A Historic Review in US$ Million for
2012-2019

Table 165: Rest of Latin America Intranasal Drug Delivery
Market Share Breakdown by Dosage Form: 2012 VS 2020 VS 2027

Table 166: Rest of Latin America Intranasal Drug Delivery
Latent Demand Forecasts in US$ Million by Application: 2020 to
2027

Table 167: Intranasal Drug Delivery Historic Demand Patterns in
Rest of Latin America by Application in US$ Million for
2012-2019

Table 168: Intranasal Drug Delivery Market Share Breakdown in
Rest of Latin America by Application: 2012 VS 2020 VS 2027

MIDDLE EAST
Table 169: The Middle East Intranasal Drug Delivery Market
Estimates and Forecasts in US$ Million by Region/Country:
2020-2027

Table 170: Intranasal Drug Delivery Market in the Middle East
by Region/Country in US$ Million: 2012-2019

Table 171: The Middle East Intranasal Drug Delivery Market
Share Breakdown by Region/Country: 2012, 2020, and 2027

Table 172: The Middle East Intranasal Drug Delivery Market
Estimates and Forecasts in US$ Million by Dosage Form: 2020 to
2027

Table 173: The Middle East Intranasal Drug Delivery Historic
Market by Dosage Form in US$ Million: 2012-2019

Table 174: Intranasal Drug Delivery Market in the Middle East:
Percentage Share Breakdown of Sales by Dosage Form for
2012,2020, and 2027

Table 175: The Middle East Intranasal Drug Delivery Market
Quantitative Demand Analysis in US$ Million by Application:
2020 to 2027

Table 176: Intranasal Drug Delivery Market in the Middle East:
Summarization of Historic Demand Patterns in US$ Million by
Application for 2012-2019

Table 177: The Middle East Intranasal Drug Delivery Market
Share Analysis by Application: 2012 VS 2020 VS 2027

IRAN
Table 178: Iranian Market for Intranasal Drug Delivery: Annual
Sales Estimates and Projections in US$ Million by Dosage Form
for the Period 2020-2027

Table 179: Intranasal Drug Delivery Market in Iran: Historic
Sales Analysis in US$ Million by Dosage Form for the Period
2012-2019

Table 180: Iranian Intranasal Drug Delivery Market Share
Analysis by Dosage Form: 2012 VS 2020 VS 2027

Table 181: Iranian Demand Estimates and Forecasts for
Intranasal Drug Delivery in US$ Million by Application: 2020 to
2027

Table 182: Iranian Intranasal Drug Delivery Market in US$
Million by Application: 2012-2019

Table 183: Intranasal Drug Delivery Market Share Shift in Iran
by Application: 2012 VS 2020 VS 2027

ISRAEL
Table 184: Israeli Intranasal Drug Delivery Market Estimates
and Forecasts in US$ Million by Dosage Form: 2020-2027

Table 185: Intranasal Drug Delivery Market in Israel in US$
Million by Dosage Form: A Historic Review for the Period
2012-2019

Table 186: Israeli Intranasal Drug Delivery Market Share
Breakdown by Dosage Form: 2012 VS 2020 VS 2027

Table 187: Israeli Intranasal Drug Delivery Addressable Market
Opportunity in US$ Million by Application: 2020-2027

Table 188: Intranasal Drug Delivery Market in Israel:
Summarization of Historic Demand in US$ Million by Application
for the Period 2012-2019

Table 189: Israeli Intranasal Drug Delivery Market Share
Analysis by Application: 2012 VS 2020 VS 2027

SAUDI ARABIA
Table 190: Saudi Arabian Intranasal Drug Delivery Market Growth
Prospects in US$ Million by Dosage Form for the Period
2020-2027

Table 191: Intranasal Drug Delivery Historic Market Analysis in
Saudi Arabia in US$ Million by Dosage Form: 2012-2019

Table 192: Saudi Arabian Intranasal Drug Delivery Market by
Dosage Form: Percentage Breakdown of Sales for 2012, 2020, and
2027

Table 193: Saudi Arabian Demand for Intranasal Drug Delivery in
US$ Million by Application: 2020 to 2027

Table 194: Intranasal Drug Delivery Market Review in Saudi
Arabia in US$ Million by Application: 2012-2019

Table 195: Saudi Arabian Intranasal Drug Delivery Market Share
Breakdown by Application: 2012 VS 2020 VS 2027

UNITED ARAB EMIRATES
Table 196: Intranasal Drug Delivery Market in the United Arab
Emirates: Recent Past, Current and Future Analysis in US$
Million by Dosage Form for the Period 2020-2027

Table 197: United Arab Emirates Intranasal Drug Delivery
Historic Market Analysis in US$ Million by Dosage Form:
2012-2019

Table 198: Intranasal Drug Delivery Market Share Distribution
in United Arab Emirates by Dosage Form: 2012 VS 2020 VS 2027

Table 199: Intranasal Drug Delivery Market in the United Arab
Emirates: Recent Past, Current and Future Analysis in US$
Million by Application for the Period 2020-2027

Table 200: United Arab Emirates Intranasal Drug Delivery
Historic Market Analysis in US$ Million by Application:
2012-2019

Table 201: Intranasal Drug Delivery Market Share Distribution
in United Arab Emirates by Application: 2012 VS 2020 VS 2027

REST OF MIDDLE EAST
Table 202: Intranasal Drug Delivery Market in Rest of Middle
East: Recent Past, Current and Future Analysis in US$ Million
by Dosage Form for the Period 2020-2027

Table 203: Rest of Middle East Intranasal Drug Delivery
Historic Market Analysis in US$ Million by Dosage Form:
2012-2019

Table 204: Rest of Middle East Intranasal Drug Delivery Market
Share Breakdown by Dosage Form: 2012 VS 2020 VS 2027

Table 205: Intranasal Drug Delivery Market in Rest of Middle
East: Annual Sales Estimates and Forecasts in US$ Million by
Application for the Period 2020-2027

Table 206: Rest of Middle East Intranasal Drug Delivery Market
in Retrospect in US$ Million by Application: 2012-2019

Table 207: Intranasal Drug Delivery Market Share Distribution
in Rest of Middle East by Application: 2012 VS 2020 VS 2027

AFRICA
Table 208: African Intranasal Drug Delivery Market Estimates
and Projections in US$ Million by Dosage Form: 2020 to 2027

Table 209: Intranasal Drug Delivery Market in Africa by Dosage
Form: A Historic Review in US$ Million for 2012-2019

Table 210: African Intranasal Drug Delivery Market Share
Breakdown by Dosage Form: 2012 VS 2020 VS 2027

Table 211: African Intranasal Drug Delivery Latent Demand
Forecasts in US$ Million by Application: 2020 to 2027

Table 212: Intranasal Drug Delivery Historic Demand Patterns in
Africa by Application in US$ Million for 2012-2019

Table 213: Intranasal Drug Delivery Market Share Breakdown in
Africa by Application: 2012 VS 2020 VS 2027

IV. COMPETITION
Total Companies Profiled: 64
Read the full report: https://www.reportlinker.com/p05436898/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.

__________________________

CONTACT: Clare: [email protected] US: (339)-368-6001 Intl: +1 339-368-6001
source: yahoo.com

LEAVE A REPLY

Please enter your comment!
Please enter your name here